110 years since the birth of a famous scientist, Professor Lieutenant General Medical Service Arcadiy Alekseevich Bocharov (23.09.1901-2707.1970). In 1961 he was deputy chief surgeon of the Department of Defense and the chief surgeon of the Central Hospital n. a. P.V. Mandryka. In 1967 A.A. Bocharov became chief surgeon of the Central Military Clinical Hospital n.a. A.A. Vishnevsky. He owns more than 80 scientific publications section of multi-volume work "The experience of Soviet medicine in the Great Patriotic War of 1941-1945".
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Valvular Heart Disease-Related Mortality Between Middle- and High-Income Countries During 2000 to 2019.
JACC Adv
December 2024
Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, Ontario, Canada.
Background: Valvular heart disease (VHD) management has evolved rapidly in recent decades, but disparities in health care access persist among countries with varying socioeconomic backgrounds.
Objectives: The purpose of this study was to investigate global mortality trends from VHD and assess the difference between middle- and high-income countries.
Methods: We obtained mortality data from the World Health Organization Mortality Database for VHD and its subgroups (rheumatic valvular disease [RVD], infective endocarditis [IE], aortic stenosis [AS], and mitral regurgitation [MR]) from 2000 to 2019.
The evolution and promise of endoscopic spine surgery.
J Spine Surg
December 2024
NeuroSpineClinic, Randwick, Sydney, Australia.
Artificial intelligence in spine care: a paradigm shift in diagnosis, surgery, and rehabilitation.
J Spine Surg
December 2024
NeuroSpineClinic, Randwick, Sydney, Australia.
Use of Gemini Bipolar Nerve Stimulator as an Alternative to Neural Integrity Monitor in Hypoglossal Nerve Interrogation During Inspire Placement.
J Oral Maxillofac Surg
December 2024
Chief Resident, University of Minnesota, Minneapolis, MN; Associate Surgeon, Oral and Maxillofacial Surgical Consultants, Minneapolis, MN. Electronic address:
The literature in botulinum toxin treatment for painful diabetic neuropathy (PDN), post traumatic neuralgia (PTN), postherpetic neuralgia (PHN) and occipital neuralgia (ON) was reviewed up to Oct 1st, 2024. Using the efficacy criteria set forth by the Assessment and Guideline subcommittee of the American Academy of Neurology, the current levels of efficacy for these conditions could be designated as followings: PDN: B (probably effective, two class II study), PTN: A (effective, two class I studies); PHN: A (effective, two class I studies), ON: (undetermined due to lack of blinded investigations). Due to the small number of patients in these studies, proof of efficacy requires conduction of controlled and blinded studies in large cohorts of patients with longer follow ups.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!